Skip to content

Percutaneous Imaging-guided Cryoblation of the Anterior Abdominal Wall Endometriosis Scars

Percutaneous Imaging-guided Cryoblation of the Anterior Abdominal Wall Endometriosis Scars

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06108167
Acronym
ENDOMET
Enrollment
29
Registered
2023-10-30
Start date
2023-05-05
Completion date
2023-11-05
Last updated
2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Keywords

Endometriosis, Endometrial cells, Radiofrequency, Anterior abdominal, Cryotherapy

Brief summary

Endometriosis is a common condition affecting 10% of women. It is characterized by the presence of ectopic endometrial cells. This pathology most frequently develops in the ovaries, utero-sacral ligaments and pelvic peritoneum, but also in the recto-sigmoid. Rarely, these lesions are found outside the pelvis, and even more exceptionally in the abdominal wall (in 0.03 to 1% of cases). Cryotherapy has already been used for many years to treat soft tissue tumors (kidney and prostate tumors). It has also been successfully used by interventional radiologists to treat parietal desmoid tumors. After discussions with radiologists, given the similarity of location and extension of wall endometriosis lesions with desmoid tumours, the successes observed, and the scarcity of studies in the literature, it seemed appropriate to the investigators to study this new therapy. The aim of this study was to investigate the efficacy of cryotherapy on parietal endometriosis lesions.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult woman (≥18 years old) Having benefited from cryotherapy of an abdominal wall endometriosis nodule between January 6, 2020 and January 2, 2023. * Subject not objecting to the reuse of their data for the purposes of this research

Exclusion criteria

* Subject having expressed its opposition to the reuse of its data for scientific research purposes.

Design outcomes

Primary

MeasureTime frame
Efficacy of cryotherapy on parietal endometriosis lesions was assessed using the a visual analogue scale (VAS) ranging from 0 to 10.Before and 6 months after the cryotherapy

Countries

France

Contacts

Primary ContactVictor GABRIELE, MD
victor.gabriele@chru-strasbourg.fr33 3 69 55 34 04

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026